BR9714384A - Uso de equeilenina como um antioxidante - Google Patents

Uso de equeilenina como um antioxidante

Info

Publication number
BR9714384A
BR9714384A BR9714384-7A BR9714384A BR9714384A BR 9714384 A BR9714384 A BR 9714384A BR 9714384 A BR9714384 A BR 9714384A BR 9714384 A BR9714384 A BR 9714384A
Authority
BR
Brazil
Prior art keywords
antioxidant
equeilenina
equilenin
pharmaceutically acceptable
provides
Prior art date
Application number
BR9714384-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Steven Jay Adelman
Dorothy Helen Prozialeck
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9714384A publication Critical patent/BR9714384A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9714384-7A 1996-12-10 1997-12-05 Uso de equeilenina como um antioxidante BR9714384A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76257996A 1996-12-10 1996-12-10
PCT/US1997/022154 WO1998025626A1 (fr) 1996-12-10 1997-12-05 Utilisation de l'equilenine comme antioxydant

Publications (1)

Publication Number Publication Date
BR9714384A true BR9714384A (pt) 2000-05-16

Family

ID=25065472

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714384-7A BR9714384A (pt) 1996-12-10 1997-12-05 Uso de equeilenina como um antioxidante

Country Status (14)

Country Link
EP (1) EP0944391A1 (fr)
JP (1) JP2001506628A (fr)
KR (1) KR20000069412A (fr)
CN (1) CN1239892A (fr)
AR (1) AR010344A1 (fr)
AU (1) AU743586B2 (fr)
BR (1) BR9714384A (fr)
CA (1) CA2272087A1 (fr)
HU (1) HUP0000569A3 (fr)
IL (1) IL130071A0 (fr)
NZ (1) NZ336343A (fr)
TW (1) TW466115B (fr)
WO (1) WO1998025626A1 (fr)
ZA (1) ZA9711052B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271221B1 (en) * 1996-12-10 2001-08-07 American Home Products Corporation Use of equilenin as an antioxidant
DE19915576A1 (de) * 1999-03-30 2000-10-05 Jenapharm Gmbh Equileninderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US20030139458A1 (en) * 2001-12-10 2003-07-24 Yansheng Du Treatment of neurodegenerative and cardiovascular disorders
CN108958639B (zh) 2017-05-19 2021-07-06 华邦电子股份有限公司 快闪存储器存储装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4937238A (en) * 1986-03-04 1990-06-26 The Board Of Regents Of The University Of Nebraska Prevention of mammary carcinoma
EP0240717A3 (fr) * 1986-03-04 1990-05-16 Board of Regents of the University of Nebraska Prévention du carcinome du sein
US5545635A (en) * 1995-05-23 1996-08-13 Eli Lilly And Company Inhibiting bone loss with equilenin

Also Published As

Publication number Publication date
WO1998025626A1 (fr) 1998-06-18
TW466115B (en) 2001-12-01
AU5370798A (en) 1998-07-03
EP0944391A1 (fr) 1999-09-29
NZ336343A (en) 2000-11-24
JP2001506628A (ja) 2001-05-22
KR20000069412A (ko) 2000-11-25
CN1239892A (zh) 1999-12-29
CA2272087A1 (fr) 1998-06-18
AU743586B2 (en) 2002-01-31
IL130071A0 (en) 2000-02-29
HUP0000569A3 (en) 2000-11-28
ZA9711052B (en) 1999-06-09
AR010344A1 (es) 2000-06-07
HUP0000569A2 (hu) 2000-10-28

Similar Documents

Publication Publication Date Title
BR9902086A (pt) Formulações farmacêuticas.
BR9813228A (pt) Formulação de 2-metil-tieno-benzodiazepina
AU1126500A (en) Marker for indicating the location of identified tissue
DE69727384D1 (de) Polykatonische sterin-derivate zur transfektion
TR199801679T2 (xx) Osteoporoz i�in birle�tirme terapisi.
ES2182088T3 (es) Antagonista de la endotelina.
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
BR0113670A (pt) Composição farmacêutica e método para tratar hipogonadismo
BR9807638A (pt) Compostos antiinflamatórios
BR9712491A (pt) Composições cosméticas
ES2179881T3 (es) Antagonistas de endotelina.
PT1119359E (pt) Formulacao de 2-metil-tieno-benzodiazepina
DE69840415D1 (de) Haemasterlin analoge
BR9707247A (pt) Diidrobenzofurano e compostos relacionados úteis como agentes antiinflamatórios
IT1282627B1 (it) Procedimento per la preparazione di perfluoropoliossialchileni perossidici
AU694663B2 (en) Agents for use against parasitic protozoa
BR9714384A (pt) Uso de equeilenina como um antioxidante
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
AU2881399A (en) N1-modified glycopeptides
FR2756888B3 (fr) Corps de palier
BR9713998A (pt) Uso de 17beta-dihidroequilenina como um antioxidante
IL139144A0 (en) Mycobacterial inhibitors
BR9714382A (pt) 17alfa-diidroequilina para uso como um antioxidante médico
MX9606009A (es) Uso de 8,9-deshidroestrona como un antioxidante.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO 8.6 DA RPI 1879 DE 09/01/2007.